Evidence map›Paper›PMID 41296812›Full record

ArticlePLoS pathogens2025

Assessing Ebola virus circulation in the Tshuapa province (Democratic Republic of the Congo): A One Health investigation of wildlife and human interactions.

Rianne van Vredendaal, Léa Joffrin, Antea Paviotti, Claude Mande, Solange Milolo, Nicolas Laurent, Léa Fourchault, Douglas Adroabadrio, Pascal Baelo, Steve Ngoy and 25 more

Abstract read
In one paragraph

Article in PLoS pathogens, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Tropical medicine and infectious disease · 2026
    Article
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Rianne van VredendaalEvolutionary Ecology Group, Department of Biology, University of Antwerp, Wilrijk, Belgium.ORCID 0000-0003-1116-0184
Léa JoffrinEvolutionary Ecology Group, Department of Biology, University of Antwerp, Wilrijk, Belgium.
Antea PaviottiCentre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
Claude MandeCentre for Biodiversity Monitoring, University of Kisangani, Kisangani, Democratic Republic of Congo.
Solange MiloloTropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Nicolas LaurentVertebrate Group, Directorate Taxonomy and Phylogeny, Royal Belgian Institute of Natural Sciences, Brussels, Belgium.
Léa FourchaultEvolutionary Ecology Group, Department of Biology, University of Antwerp, Wilrijk, Belgium.
Douglas AdroabadrioCentre for Biodiversity Monitoring, University of Kisangani, Kisangani, Democratic Republic of Congo.
Pascal BaeloCentre for Biodiversity Monitoring, University of Kisangani, Kisangani, Democratic Republic of Congo.
Steve NgoyCentre for Biodiversity Monitoring, University of Kisangani, Kisangani, Democratic Republic of Congo.
Papy AnsobiEcology and Control of Infectious Diseases Unit, Basic Sciences Department, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Casimir NebesseCentre for Biodiversity Monitoring, University of Kisangani, Kisangani, Democratic Republic of Congo.
Martine PeetersTransVIHMI, University of Montpellier, Institute for Research and Sustainable Development (IRD), INSERM, Montpellier, France.
Ahidjo AyoubaTransVIHMI, University of Montpellier, Institute for Research and Sustainable Development (IRD), INSERM, Montpellier, France.
Maeliss ChampagneTransVIHMI, University of Montpellier, Institute for Research and Sustainable Development (IRD), INSERM, Montpellier, France.
Julie BouillinTransVIHMI, University of Montpellier, Institute for Research and Sustainable Development (IRD), INSERM, Montpellier, France.
Jana TĕšíkováEvolutionary Ecology Group, Department of Biology, University of Antwerp, Wilrijk, Belgium.
Natalie Van HoutteEvolutionary Ecology Group, Department of Biology, University of Antwerp, Wilrijk, Belgium.
Sophie GryseelsEvolutionary Ecology Group, Department of Biology, University of Antwerp, Wilrijk, Belgium.
Maha SalloumCentre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
Freddy BikioliTropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Séverine ThysASTRE, French Agricultural Research Centre for International Development (CIRAD), Montpellier, France.
Jimmy MpatoBoende General Hospital of Reference, Boende, Democratic Republic of Congo.
Ruben IlongaCentral Office of Boende Health District, Boende, Democratic Republic of Congo.
Henri KiminaAnthropology Department, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Ynke LarivièreCentre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
Gwen LemeyCentre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
Pierre Van DammeCentre for the Evaluation of Vaccination, Vaccine and Infectious Disease Institute, University of Antwerp, Wilrijk, Belgium.
Jean-Pierre Van GeertruydenGlobal Health Institute, Department of Family Medicine and Population Health, University of Antwerp, Wilrijk Belgium.
Hypolite Muhindo-MavokoTropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Patrick MitashiTropical Medicine Department, University of Kinshasa, Kinshasa, Democratic Republic of Congo.
Herwig LeirsEvolutionary Ecology Group, Department of Biology, University of Antwerp, Wilrijk, Belgium.
Erik VerheyenEvolutionary Ecology Group, Department of Biology, University of Antwerp, Wilrijk, Belgium.
Guy-Crispin GembuCentre for Biodiversity Monitoring, University of Kisangani, Kisangani, Democratic Republic of Congo.
Joachim MariënEvolutionary Ecology Group, Department of Biology, University of Antwerp, Wilrijk, Belgium.

Funding

Coalition for Epidemic Preparedness InnovationsEuropean Federation of Pharmaceutical Industries and AssociationsEuropean UnionEuropean Union’s Horizon 2020Innovative Medicines Initiative 2
6 · The paper itself

Abstract

The wildlife reservoir and spillover mechanisms of Ebola virus remain elusive despite extensive research efforts in endemic areas. This study employed a One Health approach to examine the virus' circulation in wildlife and the associated human exposure risks in the Tshuapa province of the Democratic Republic of the Congo. We screened 1049 samples from 919 animals, predominantly small mammals, collected in 2021, and 380 samples from inhabitants of Inkanamongo village, the site of an Ebola virus disease outbreak in 2014. These samples were screened for evidence of current (RNA) or past (IgG antibodies) Ebola virus infections. We also conducted interviews with 167 individuals in the surrounding districts to assess their interactions with wildlife. While no Ebola virus RNA was detected in the wildlife samples, anti-orthoebolavirus IgG antibodies were found in 13 bats and 38 rodents. Among the human participants, 120 individuals had IgG antibodies against at least 1 orthoebolavirus antigen, with 12 showing seropositivity for 2 antigens of the same orthoebolavirus, despite not having a prior Ebola disease diagnosis. Furthermore, the majority of respondents reported frequent visits to the forest to hunt a variety of wild animals, particularly ungulates and rodents, which could account for occasional viral spillovers. The absence of active Ebola virus circulation in wildlife may reflect seasonal patterns in reservoir ecology, as those observed in bats. Similarly, seasonal human activities, such as hunting and foraging, may result in periodic exposure risks. These findings highlight the importance of continuous, multidisciplinary surveillance to monitor changes in seasonal spillover risks.

Indexed as

Animals, WildEbolavirusHemorrhagic Fever, EbolaOne HealthAdolescentAdultAgedAnimalsAntibodies, ViralChildChiropteraDemocratic Republic of the CongoDisease OutbreaksDisease ReservoirsFemaleHumansAntibodies, ViralImmunoglobulin G

Identifiers

PMID41296812
PMCPMC12680337

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.